129 related articles for article (PubMed ID: 38224275)
1. Assessment of long noncoding RNA CCAT1 using real time-polymerase chain reaction in colorectal cancer patients.
Mahmoud AA; Mohamed HO; Shehata MR; Refae AAS; Abd El Salam MH; Seddik MI
Egypt J Immunol; 2024 Jan; 31(1):106-115. PubMed ID: 38224275
[TBL] [Abstract][Full Text] [Related]
2. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.
Ozawa T; Matsuyama T; Toiyama Y; Takahashi N; Ishikawa T; Uetake H; Yamada Y; Kusunoki M; Calin G; Goel A
Ann Oncol; 2017 Aug; 28(8):1882-1888. PubMed ID: 28838211
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of circulating plasma long noncoding RNAs in colorectal cancer: The relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks.
Abedini P; Fattahi A; Agah S; Talebi A; Beygi AH; Amini SM; Mirzaei A; Akbari A
J Cell Physiol; 2019 Dec; 234(12):22028-22033. PubMed ID: 31093977
[TBL] [Abstract][Full Text] [Related]
4. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
Zhao W; Song M; Zhang J; Kuerban M; Wang H
Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression.
Shang A; Wang W; Gu C; Chen W; Lu W; Sun Z; Li D
Aging (Albany NY); 2020 May; 12(9):8301-8320. PubMed ID: 32380476
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.
Alaiyan B; Ilyayev N; Stojadinovic A; Izadjoo M; Roistacher M; Pavlov V; Tzivin V; Halle D; Pan H; Trink B; Gure AO; Nissan A
BMC Cancer; 2013 Apr; 13():196. PubMed ID: 23594791
[TBL] [Abstract][Full Text] [Related]
7. Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT-PNA molecular beacons.
Kam Y; Rubinstein A; Naik S; Djavsarov I; Halle D; Ariel I; Gure AO; Stojadinovic A; Pan H; Tsivin V; Nissan A; Yavin E
Cancer Lett; 2014 Sep; 352(1):90-6. PubMed ID: 23416875
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNAs as Prognostic Markers for Colorectal Cancer in Saudi Patients.
Siddique H; Al-Ghafari A; Choudhry H; AlTurki S; Alshaibi H; Al Doghaither H; Alsufiani H
Genet Test Mol Biomarkers; 2019 Aug; 23(8):509-514. PubMed ID: 31328973
[No Abstract] [Full Text] [Related]
9. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CCAT1 polymorphisms are associated with the risk of colorectal cancer.
Li Y; Jing F; Ding Y; He Q; Zhong Y; Fan C
Cancer Genet; 2018 Apr; 222-223():13-19. PubMed ID: 29666003
[TBL] [Abstract][Full Text] [Related]
11. lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer.
Thiele JA; Hosek P; Kralovcova E; Ostasov P; Liska V; Bruha J; Vycital O; Rosendorf J; Opattova A; Horak J; Kralickova M; Vodicka P; Pitule P
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205577
[TBL] [Abstract][Full Text] [Related]
12. LncRNA signature in colorectal cancer.
Ghafouri-Fard S; Hussen BM; Gharebaghi A; Eghtedarian R; Taheri M
Pathol Res Pract; 2021 Jun; 222():153432. PubMed ID: 33857856
[TBL] [Abstract][Full Text] [Related]
13. CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p.
Ma D; Cao Y; Wang Z; He J; Chen H; Xiong H; Ren L; Shen C; Zhang X; Yan Y; Yan T; Guo F; Xuan B; Cui Z; Ye G; Fang JY; Chen H; Hong J
Inflamm Bowel Dis; 2019 Apr; 25(5):862-874. PubMed ID: 30615124
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes.
Franz C; Wuehrl M; Hartmann S; Klupp F; Schmidt T; Schneider M
PLoS One; 2023; 18(6):e0286486. PubMed ID: 37347737
[TBL] [Abstract][Full Text] [Related]
15. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion.
He X; Tan X; Wang X; Jin H; Liu L; Ma L; Yu H; Fan Z
Tumour Biol; 2014 Dec; 35(12):12181-8. PubMed ID: 25185650
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor B-MYB activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer.
Liu F; Wang Y; Cao Y; Wu Z; Ma D; Cai J; Sha J; Chen Q
Chem Biol Interact; 2023 Apr; 374():110412. PubMed ID: 36812959
[TBL] [Abstract][Full Text] [Related]
18. Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis.
Thean LF; Blöcker C; Li HH; Lo M; Wong M; Tang CL; Tan EKW; Rozen SG; Cheah PY
Sci Rep; 2021 Jan; 11(1):404. PubMed ID: 33432117
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
Yang C; Pan Y; Deng SP
BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1.
Li J; Qi Y
Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
